Status:

COMPLETED

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Lead Sponsor:

Vical

Conditions:

Metastatic Melanoma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

To compare the safety and efficacy of Allovectin-7® versus Dacarbazine (DTIC)or Temozolomide (TMZ) in subjects with recurrent stage 3 or stage 4 melanoma.

Detailed Description

Eligible patients will have a 66% chance of receiving Allovectin-7® alone (an investigational product designed to train your body's immune system to recognize and destroy tumor cells) vs. a 33% chance...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Potential study participants must meet the following criteria):
  • Confirmed Stage 3 or Stage 4 melanoma that may have had previous treatment via surgery, radiation or biologic drugs (typically Interferon Alpha or Interleukin-2)
  • At least 1 melanoma tumor that is 1cm x 1cm or greater in size (about the size of a dime) and can be injected
  • Normal blood chemistries and blood cell counts
  • At least 18 years old and able and willing to provide informed consent to participate
  • Exclusion Criteria (Potential study participants will not be eligible with the following):
  • Previous chemotherapy treatment for melanoma
  • Melanoma lesions in the brain or liver (however, lesions in the lungs are allowed)
  • If surgical removal of all lesions would be possible and could be curative
  • Any melanoma tumors greater than 10cm x 10cm in size
  • Known condition resulting in a suppressed immune system
  • Female subjects who are pregnant

Exclusion

    Key Trial Info

    Start Date :

    October 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2013

    Estimated Enrollment :

    390 Patients enrolled

    Trial Details

    Trial ID

    NCT00395070

    Start Date

    October 1 2006

    End Date

    July 1 2013

    Last Update

    September 13 2013

    Active Locations (88)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 22 (88 locations)

    1

    Location #40

    Tucson, Arizona, United States, 85724

    2

    Location #9

    Little Rock, Arkansas, United States, 72205

    3

    Location #1

    Bakersfield, California, United States, 93309

    4

    Location #24

    San Diego, California, United States, 92093

    A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma | DecenTrialz